Startseite
Impressum
Datenschutz
 
Volume 36, 10 Juni 2005 6/2005
 
  SPOT ON
 

Drug companies: who belongs to whom?

 
  THERAPIES FROM A CRITICAL VIEWPOINT
 

Breast cancer: the value of systemic adjuvant therapy
Vitamin D (e.g. VIGANTOLETTEN) and calcium for osteoporosis in the elderly

 
  BEWARE MISINFORMATION
 

Levodopa-benserazid combination RESTEX: according to SPC now with fewer side effects?

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Animadversion on antidepressants: what to do?

Bevacizumab (AVASTIN): inhibitior of angiogenesis for colorectal cancer

 
  IN BRIEF
 

Radical prostatectomy reduces mortality in early prostate cancer
Cox-2-inhibitor parecoxib (DYNASTAT) off the market in Switzerland

 
  CURRENT ADR NETWORK REPORT
 

Skin necrosis after injection of glatiramer acetate (COPAXONE)

 
  SIDE EFFECTS
 

Bisphosphonates: non-traumatic fractures with protracted healing with alendronat (FOSAMAX)
Exophtalmos with glitazones

 
© arznei-telegramm 6/2005